NASDAQ · SHCHealthcareHealth Services

Sotera Health Company Common Stock (SHC)

$15.87−3.17%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$15.87▲ 0.38% in range
Nov 5, 2025Low $13.13 · High $19.57Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

Sotera Health closed at $15.87 on Nov 5, down 3.17%, 18.9% below its 52-week closing high. Volume of 3.1M shares was 1.27× its 20-day average (above normal).

Split-adjusted performance: -11.3% over one month, +1.3% over six months, -3.4% over one year.

In the quarter ended Sep 30, 2026, revenue was $324.89M, up 4.4% from a year earlier, with a net margin of 18.0%.

Short interest was 16.1M shares at the Oct 15 settlement, up 9.1% from the prior report (6.2% of float, 8.4 days to cover).

Market cap$4.53B285.6M shares
Revenue · quarter$324.9M+4.4% YoY
Diluted EPS$0.20+17.6% YoY
P/E · TTM26.1×P/S 3.7×
Net margin18.0%Gross 55.6%
Dividend yieldNone
52-week range13.13 – 19.57−18.9% from high
Volume3.1M1.27× 20-day avg
Volatility · 60d30.9%Annualised
Short % of float6.2%8.4 days to cover
Net cash-$1.83BCash $412.4M
Next earnings—Not scheduled
Split-adjusted performance
1W −15.1%1M −11.3%3M −15.9%6M +1.3%YTD −10.0%1Y −3.4%3Y +25.4%5Y −36.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Health Services

Percentile among 20 companies (100 = best)

6-month momentum37
Revenue growth35
Net margin94
Value (low P/E)78
Size90

Industry medians: 6-month return +11.1%, revenue growth +7.2%, net margin 3.0%, P/E 72.1×.

Short interest

Details →
Shares short16.1M+9.1% vs prior
Days to cover8.4Settled Oct 15
% of float6.2%
Short vol. 10d55.2%of daily volume

Closest peers by size in Health Services

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SHCSotera Health$15.87−3.17%+1.3%+4.4%18.0%26.1$4.53B
LFSTLifeStance Health Group$13.43−5.49%+51.8%+26.1%5.4%100.9$5.11BCompare
PRVAPrivia Health Group$23.94+6.88%−0.2%+21.4%1.4%108.7$3.06BCompare
PGNYProgyny$34.37+14.19%+79.4%+5.3%8.0%33.5$2.64BCompare
WGSGeneDx Holdings$64.36−7.18%+58.9%+11.4%−15.5%—$1.92BCompare
AGLagilon health$113.77+18.23%+87.6%+5.9%2.3%—$1.91BCompare
DVADaVita$194.82+1.12%−0.7%+3.3%6.5%13.3$12.25BCompare
USPHUS Physical Therapy$97.20+8.99%+64.7%+8.5%1.8%545.5$1.45BCompare
PNTGThe Pennant Group$40.00−9.17%+12.0%+35.8%3.0%43.2$1.40BCompare

Quick answers

What does Sotera Health do?
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs.
What is SHC's market cap?
$4.53B, based on the Nov 5 close of $15.87.
What is SHC's P/E ratio?
26.1× trailing-twelve-month earnings of $173.47M.
Does Sotera Health pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SHC is sold short?
16.1M shares, 6.2% of float, as of Oct 15, 2026.
What sector is SHC in?
Healthcare, in the Health Services industry.

About Sotera Health

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

HQ: Broadview Heights, OH3,000 employeesListed Nov 20, 2020soterahealth.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology